Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel database.
L'Orphelin JM, Le Naour S, Dalle S, Varey E, Dupuy A, Montaudie H, Lesage C, Mortier L, Leccia MT, Celerier P, Skowron F, Meyer N, Maubec E, Amini-Adle M, Dalac-Rat S, Dutriaux C, Khammari A, Dompmartin A, Dreno B; RIC-Mel NETWORK. L'Orphelin JM, et al. Among authors: maubec e. Eur J Dermatol. 2022 Nov 1;32(6):691-697. doi: 10.1684/ejd.2022.4357. Eur J Dermatol. 2022. PMID: 36856380 English.
Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France.
Kandel M, Bardet A, Dalle S, Allayous C, Mortier L, Guillot B, Dutriaux C, Leccia MT, Dalac S, Montaudie H, Saiag P, Legoupil D, Brunet-Possenti F, Arnault JP, Quatrebarbes J, Beylot-Barry M, Maubec E, Lesimple T, Aubin F, Grob JJ, Granel-Brocard F, Stoebner PE, Dupuy A, Dreno B, Michiels S, Lebbe C, Borget I. Kandel M, et al. Among authors: maubec e. Curr Oncol. 2022 Nov 27;29(12):9255-9270. doi: 10.3390/curroncol29120725. Curr Oncol. 2022. PMID: 36547139 Free PMC article.
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort.
Girod M, Dalle S, Mortier L, Dalac S, Leccia MT, Dutriaux C, Montaudié H, de Quatrebarbes J, Lesimple T, Brunet-Possenti F, Saiag P, Maubec E, Legoupil D, Stoebner PE, Arnault JP, Lefevre W, Lebbe C, Dereure O. Girod M, et al. Among authors: maubec e. JCO Precis Oncol. 2022 Nov;6:e2200075. doi: 10.1200/PO.22.00075. JCO Precis Oncol. 2022. PMID: 36356284
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.
Rousset P, Dalle S, Mortier L, Dereure O, Dalac S, Dutriaux C, Leccia MT, Legoupil D, Brunet-Possenti F, De Quatrebarbes J, Grob JJ, Saiag P, Maubec E, Stoebner PE, Granel-Brocard F, Arnault JP, Allayous C, Oriano B, Lebbe C, Montaudié H. Rousset P, et al. Among authors: maubec e. J Am Acad Dermatol. 2023 Apr;88(4):808-815. doi: 10.1016/j.jaad.2022.11.040. Epub 2022 Dec 19. J Am Acad Dermatol. 2023. PMID: 36543626
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial.
Véron M, Chevret S, Grob JJ, Beylot-Barry M, Saiag P, Fléchon A, You B, Maubec E, Jouary T, Toulemonde E, Jamme P, Gambotti L, Lamrani-Ghaouti A, Dupuy A, Lebbe C, Seguin NB, Houede N, Leccia MT, Le Du F, de Pontville M, Gaudy-Marquestre C, Guillot B, Simon C, Marabelle A, Mortier L. Véron M, et al. Among authors: maubec e. Eur J Cancer. 2022 Dec;177:103-111. doi: 10.1016/j.ejca.2022.09.013. Epub 2022 Oct 11. Eur J Cancer. 2022. PMID: 36335780 Clinical Trial.
Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients.
Reichert C, Baldini C, Mezghani S, Maubec E, Longvert C, Mortier L, Quereux G, Jannic A, Machet L, de Quatrebarbes J, Nardin C, Beneton N, Amini Adle M, Funck-Brentano E, Descamps V, Hachon L, Malissen N, Baroudjian B, Brunet-Possenti F; Groupe de Cancérologie Cutanée. Reichert C, et al. Among authors: maubec e. Cancers (Basel). 2023 Aug 30;15(17):4330. doi: 10.3390/cancers15174330. Cancers (Basel). 2023. PMID: 37686606 Free PMC article.
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study.
Khelef K, Maubec E, Jeudy G, Bonniaud B, Pham-Ledard A, Herms F, Aubin F, Beneton N, Dinulescu M, Jannic A, Duval-Modeste A, Archier E, Berthin C, Grange F, Arnault J, Heidelberger V, Moncourier M, Mansard S, Brunet-Possenti F, Triller R, Pracht M, Dumas M, Lauche O, Mortier L, Bedane C, Dalac Rat S. Khelef K, et al. Among authors: maubec e. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e71-e73. doi: 10.1111/jdv.19435. Epub 2023 Sep 23. J Eur Acad Dermatol Venereol. 2024. PMID: 37595320 No abstract available.
Common skin cancers in porokeratosis.
Maubec E, Duvillard P, Margulis A, Bachollet B, Degois G, Avril MF. Maubec E, et al. Br J Dermatol. 2005 Jun;152(6):1389-91. doi: 10.1111/j.1365-2133.2005.06639.x. Br J Dermatol. 2005. PMID: 15949029 No abstract available.
141 results